VPC 23019

Cat. No. M7465

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

VPC 23019 is a sphingosine-1-phosphate receptor antagonist. VPC 23019 inhibits S1P₁ and S1P₃ receptors (pK_i values are 7.86 and 5.93 respectively).

Molecular Weight	372.4
Formula	C17H29N2O5P
CAS Number	449173-19-7
Solubility (25°C)	2eq. NaOH 18.62 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related S1P Receptor Products
VTX-002 VTX-002 is an orally active, selective S1P receptor 1 modulator for studies related to ulcerative colitis.
TRV045 TRV045 is an S1P receptor modulator that can be used in studies related to central nervous system disorders.
S1PR1 modulator 1 S1PR1 modulator 1 is a selective S1PR1 inhibitor, with a pIC50 of 7.6, with >40- and >80-fold selectivity, over the other S1PR isoforms S1PR2/3/4.
Ozanimod hydrochloride Ozanimod (RPC-1063) hydrochloride, a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod hydrochloride has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod hydrochloride can be used for the research of relapsing multiple sclerosis (MS) .
Icanbelimod Icanbelimod (S1p receptor agonist 1) is a potent and orally active S1P1 receptor agonist, exhibits an activity of inducing S1P1 internalization (EC50=9.83 nM). Icanbelimod has the potential for the study of arthritis and EAE (experimental autoimmune encephalitis).

Catalog